Found: 47
Select item for more details and to access through your institution.
Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: Analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials.
- Published in:
- 2019
- By:
- Publication type:
- journal article
ASO Visual Abstract: Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Clinically Node-Negative T1 Triple-Negative Breast Cancer.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Clinically Node Negative T1 Triple Negative Breast Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 12, p. 7026, doi. 10.1245/s10434-023-13977-4
- By:
- Publication type:
- Article
Platelet count is a sensitive predictor of autologous peripheral blood progenitor cell collection yield in previously treated plasma cell disease patients.
- Published in:
- Transfusion, 2008, v. 48, n. 6, p. 1106, doi. 10.1111/j.1537-2995.2008.01651.x
- By:
- Publication type:
- Article
Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy-a sub-analysis of the ALTTO study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 203, n. 3, p. 497, doi. 10.1007/s10549-023-07159-9
- By:
- Publication type:
- Article
Correction to: Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub‑analysis of the ALTTO trial (BIG 2‑06; NCCTG (Alliance) N063D).
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D).
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 1, p. 107, doi. 10.1007/s10549-020-05915-9
- By:
- Publication type:
- Article
N083E (Alliance): long-term outcomes of patients treated in a pilot phase II study of docetaxel, carboplatin, trastuzumab, and lapatinib as adjuvant therapy for early-stage HER2-positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 182, n. 3, p. 613, doi. 10.1007/s10549-020-05709-z
- By:
- Publication type:
- Article
Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 177, n. 1, p. 103, doi. 10.1007/s10549-019-05284-y
- By:
- Publication type:
- Article
Erratum to: Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial.
- Published in:
- 2017
- By:
- Publication type:
- Erratum
Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 165, n. 2, p. 329, doi. 10.1007/s10549-017-4304-7
- By:
- Publication type:
- Article
Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 153, n. 2, p. 435, doi. 10.1007/s10549-015-3545-6
- By:
- Publication type:
- Article
Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer (NCCTG N1031, Alliance).
- Published in:
- Oncologist, 2022, v. 27, n. 5, p. 338, doi. 10.1093/oncolo/oyab065
- By:
- Publication type:
- Article
Intra‐CSF topotecan in treatment of breast cancer patients with leptomeningeal metastases.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 21, p. 7935, doi. 10.1002/cam4.3422
- By:
- Publication type:
- Article
Efficacy of Bevacizumab-Capecitabine in Combination for the First-Line Treatment of Metastatic Breast Cancer.
- Published in:
- Breast Cancer: Basic & Clinical Research, 2011, n. 5, p. 239, doi. 10.4137/BCBCR.S7379
- By:
- Publication type:
- Article
Correction to: Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Dual HER2 blockade in the neoadjuvant and adjuvant treatment of HER2-positive breast cancer.
- Published in:
- Breast Cancer: Targets & Therapy, 2015, v. 7, p. 321, doi. 10.2147/BCTT.S90627
- By:
- Publication type:
- Article
Current strategies for the prevention of breast cancer.
- Published in:
- Breast Cancer: Targets & Therapy, 2014, v. 6, p. 59, doi. 10.2147/BCTT.S39114
- By:
- Publication type:
- Article
Personalized Management of Chemotherapy‐Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance).
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 4, p. 444, doi. 10.1002/jcph.1559
- By:
- Publication type:
- Article
Soluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2-positive breast cancer receiving chemotherapy with or without trastuzumab: Results from North Central Cancer Treatment Group adjuvant trial N9831.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 15, p. 2675, doi. 10.1002/cncr.28130
- By:
- Publication type:
- Article
Effect of body mass index on tumor characteristics and disease-free survival in patients from the HER2-positive adjuvant trastuzumab trial N9831.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 13, p. 2447, doi. 10.1002/cncr.28051
- By:
- Publication type:
- Article
DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Impact of the COVID‐19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 6, p. 7381, doi. 10.1002/cam4.5439
- By:
- Publication type:
- Article
Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabepilone: CALGB 40502 (Alliance).
- Published in:
- AAPS Journal, 2017, v. 19, n. 5, p. 1411, doi. 10.1208/s12248-017-0101-9
- By:
- Publication type:
- Article
A Church-Based, Spanish-Language Community Education Breast Health Program Increases Awareness and Utilization of Breast Diagnostic Services Among Hispanics.
- Published in:
- Journal of Higher Education Outreach & Engagement, 2014, v. 18, n. 1, p. 43
- By:
- Publication type:
- Article
Case Report: Alpelisib-Induced Drug Reaction With Eosinophilia and Systemic Symptoms: A Rare Manifestation of a Common Side Effect.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.726785
- By:
- Publication type:
- Article
Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome‐Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 219, doi. 10.1002/cpt.1359
- By:
- Publication type:
- Article
RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 138, n. 2, p. 427, doi. 10.1007/s10549-013-2469-2
- By:
- Publication type:
- Article
Efficacy of ixabepilone in ER/PR/HER2-negative (triple-negative) breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 121, n. 2, p. 261, doi. 10.1007/s10549-010-0824-0
- By:
- Publication type:
- Article
Adjuvant therapy of triple negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 120, n. 2, p. 285, doi. 10.1007/s10549-010-0736-z
- By:
- Publication type:
- Article
Issues and controversies in the treatment of HER2 positive metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2008, v. 109, n. 1, p. 1, doi. 10.1007/s10549-007-9636-2
- By:
- Publication type:
- Article
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00500-3
- By:
- Publication type:
- Article
PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00452-8
- By:
- Publication type:
- Article
Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients: A Post-hoc Analysis of the NCCTG-N9831 (Alliance) Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Phase I Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer Patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
N0436 (Alliance): A Phase II Trial of Irinotecan With Cetuximab in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane-Containing Therapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Rifaximin for Pertuzumab-Related GI Toxicities.
- Published in:
- Frontiers in Oncology, 2017, p. 1, doi. 10.3389/fonc.2017.00168
- By:
- Publication type:
- Article
Assessment of Tumor Heterogeneity, as Evidenced by Gene Expression Profiles, Pathway Activation, and Gene Copy Number, in Patients with Multifocal Invasive Lobular Breast Tumors.
- Published in:
- PLoS ONE, 2016, v. 11, n. 4, p. 1, doi. 10.1371/journal.pone.0153411
- By:
- Publication type:
- Article
Correction: Folate Receptor-α (FOLR1) Expression and Function in Triple Negative Tumors.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0127133
- By:
- Publication type:
- Article
Author reply.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 6, p. 1212
- By:
- Publication type:
- Article
Thalidomide therapy in adult patients with myelodysplastic syndrome.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 4, p. 767, doi. 10.1002/cncr.22047
- By:
- Publication type:
- Article